0
     

Report Added
Report already added
CAR T-Cell Immunotherapy Market, Global Outlook and Forecast 2022-2028

CAR T-Cell Immunotherapy Market, Global Outlook and Forecast 2022-2028

CAR T-Cell Immunotherapy is a new type of cancer treatment. This emerging treatment represents one of the biggest breakthroughs since the introduction of chemotherapy. T cells is a type of white blood cell extracted from the patient’s blood by doctors, and added an artificial receptor to their surface. When infused into a patient, the cells get multiplied and stay in the body as “living drugs” and help in detecting and fighting cancer. CAR-T cell therapy is defined as a type of immunotherapy that teaches T cells to recognize and destroy cancer.
This report contains market size and forecasts of CAR T-Cell Immunotherapy in Global, including the following market information:

Global CAR T-Cell Immunotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global CAR T-Cell Immunotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of CAR T-Cell Immunotherapy include AbbVie, Celgene, Kite Pharma, Oxford BioMedica, Novartis, Gilead, Pfizer, Cellectis and Bellicum, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CAR T-Cell Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global CAR T-Cell Immunotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global CAR T-Cell Immunotherapy Market Segment Percentages, by Type, 2021 (%)
Monotherapy
Combination Therapy
Global CAR T-Cell Immunotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global CAR T-Cell Immunotherapy Market Segment Percentages, by Application, 2021 (%)
Hematologic Malignancies
Solid Malignancies
Global CAR T-Cell Immunotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global CAR T-Cell Immunotherapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR T-Cell Immunotherapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies CAR T-Cell Immunotherapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 CAR T-Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell Immunotherapy Overall Market Size
2.1 Global CAR T-Cell Immunotherapy Market Size: 2021 VS 2028
2.2 Global CAR T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-Cell Immunotherapy Players in Global Market
3.2 Top Global CAR T-Cell Immunotherapy Companies Ranked by Revenue
3.3 Global CAR T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 CAR T-Cell Immunotherapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies CAR T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-Cell Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 CAR T-Cell Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global CAR T-Cell Immunotherapy Market Size Markets, 2021 & 2028
4.1.2 Monotherapy
4.1.3 Combination Therapy
4.2 By Type - Global CAR T-Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global CAR T-Cell Immunotherapy Revenue, 2017-2022
4.2.2 By Type - Global CAR T-Cell Immunotherapy Revenue, 2023-2028
4.2.3 By Type - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR T-Cell Immunotherapy Market Size, 2021 & 2028
5.1.2 Hematologic Malignancies
5.1.3 Solid Malignancies
5.2 By Application - Global CAR T-Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global CAR T-Cell Immunotherapy Revenue, 2017-2022
5.2.2 By Application - Global CAR T-Cell Immunotherapy Revenue, 2023-2028
5.2.3 By Application - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global CAR T-Cell Immunotherapy Market Size, 2021 & 2028
6.2 By Region - Global CAR T-Cell Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global CAR T-Cell Immunotherapy Revenue, 2017-2022
6.2.2 By Region - Global CAR T-Cell Immunotherapy Revenue, 2023-2028
6.2.3 By Region - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America CAR T-Cell Immunotherapy Revenue, 2017-2028
6.3.2 US CAR T-Cell Immunotherapy Market Size, 2017-2028
6.3.3 Canada CAR T-Cell Immunotherapy Market Size, 2017-2028
6.3.4 Mexico CAR T-Cell Immunotherapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe CAR T-Cell Immunotherapy Revenue, 2017-2028
6.4.2 Germany CAR T-Cell Immunotherapy Market Size, 2017-2028
6.4.3 France CAR T-Cell Immunotherapy Market Size, 2017-2028
6.4.4 U.K. CAR T-Cell Immunotherapy Market Size, 2017-2028
6.4.5 Italy CAR T-Cell Immunotherapy Market Size, 2017-2028
6.4.6 Russia CAR T-Cell Immunotherapy Market Size, 2017-2028
6.4.7 Nordic Countries CAR T-Cell Immunotherapy Market Size, 2017-2028
6.4.8 Benelux CAR T-Cell Immunotherapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia CAR T-Cell Immunotherapy Revenue, 2017-2028
6.5.2 China CAR T-Cell Immunotherapy Market Size, 2017-2028
6.5.3 Japan CAR T-Cell Immunotherapy Market Size, 2017-2028
6.5.4 South Korea CAR T-Cell Immunotherapy Market Size, 2017-2028
6.5.5 Southeast Asia CAR T-Cell Immunotherapy Market Size, 2017-2028
6.5.6 India CAR T-Cell Immunotherapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America CAR T-Cell Immunotherapy Revenue, 2017-2028
6.6.2 Brazil CAR T-Cell Immunotherapy Market Size, 2017-2028
6.6.3 Argentina CAR T-Cell Immunotherapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR T-Cell Immunotherapy Revenue, 2017-2028
6.7.2 Turkey CAR T-Cell Immunotherapy Market Size, 2017-2028
6.7.3 Israel CAR T-Cell Immunotherapy Market Size, 2017-2028
6.7.4 Saudi Arabia CAR T-Cell Immunotherapy Market Size, 2017-2028
6.7.5 UAE CAR T-Cell Immunotherapy Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie CAR T-Cell Immunotherapy Major Product Offerings
7.1.4 AbbVie CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 Celgene
7.2.1 Celgene Corporate Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene CAR T-Cell Immunotherapy Major Product Offerings
7.2.4 Celgene CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.2.5 Celgene Key News
7.3 Kite Pharma
7.3.1 Kite Pharma Corporate Summary
7.3.2 Kite Pharma Business Overview
7.3.3 Kite Pharma CAR T-Cell Immunotherapy Major Product Offerings
7.3.4 Kite Pharma CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.3.5 Kite Pharma Key News
7.4 Oxford BioMedica
7.4.1 Oxford BioMedica Corporate Summary
7.4.2 Oxford BioMedica Business Overview
7.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Major Product Offerings
7.4.4 Oxford BioMedica CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.4.5 Oxford BioMedica Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis CAR T-Cell Immunotherapy Major Product Offerings
7.5.4 Novartis CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Gilead
7.6.1 Gilead Corporate Summary
7.6.2 Gilead Business Overview
7.6.3 Gilead CAR T-Cell Immunotherapy Major Product Offerings
7.6.4 Gilead CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.6.5 Gilead Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer CAR T-Cell Immunotherapy Major Product Offerings
7.7.4 Pfizer CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.7.5 Pfizer Key News
7.8 Cellectis
7.8.1 Cellectis Corporate Summary
7.8.2 Cellectis Business Overview
7.8.3 Cellectis CAR T-Cell Immunotherapy Major Product Offerings
7.8.4 Cellectis CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.8.5 Cellectis Key News
7.9 Bellicum
7.9.1 Bellicum Corporate Summary
7.9.2 Bellicum Business Overview
7.9.3 Bellicum CAR T-Cell Immunotherapy Major Product Offerings
7.9.4 Bellicum CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.9.5 Bellicum Key News
7.10 Mustang Bio
7.10.1 Mustang Bio Corporate Summary
7.10.2 Mustang Bio Business Overview
7.10.3 Mustang Bio CAR T-Cell Immunotherapy Major Product Offerings
7.10.4 Mustang Bio CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.10.5 Mustang Bio Key News
7.11 CARsgen Therapeutics
7.11.1 CARsgen Therapeutics Corporate Summary
7.11.2 CARsgen Therapeutics Business Overview
7.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Major Product Offerings
7.11.4 CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.11.5 CARsgen Therapeutics Key News
7.12 Xyphos
7.12.1 Xyphos Corporate Summary
7.12.2 Xyphos Business Overview
7.12.3 Xyphos CAR T-Cell Immunotherapy Major Product Offerings
7.12.4 Xyphos CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.12.5 Xyphos Key News
7.13 Minerva Biotechnologies
7.13.1 Minerva Biotechnologies Corporate Summary
7.13.2 Minerva Biotechnologies Business Overview
7.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Major Product Offerings
7.13.4 Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.13.5 Minerva Biotechnologies Key News
7.14 Adaptimmune
7.14.1 Adaptimmune Corporate Summary
7.14.2 Adaptimmune Business Overview
7.14.3 Adaptimmune CAR T-Cell Immunotherapy Major Product Offerings
7.14.4 Adaptimmune CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.14.5 Adaptimmune Key News
7.15 Ziopharm Oncology
7.15.1 Ziopharm Oncology Corporate Summary
7.15.2 Ziopharm Oncology Business Overview
7.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Major Product Offerings
7.15.4 Ziopharm Oncology CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.15.5 Ziopharm Oncology Key News
7.16 Aurora Biopharma
7.16.1 Aurora Biopharma Corporate Summary
7.16.2 Aurora Biopharma Business Overview
7.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Major Product Offerings
7.16.4 Aurora Biopharma CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.16.5 Aurora Biopharma Key News
7.17 Creative Biolabs
7.17.1 Creative Biolabs Corporate Summary
7.17.2 Creative Biolabs Business Overview
7.17.3 Creative Biolabs CAR T-Cell Immunotherapy Major Product Offerings
7.17.4 Creative Biolabs CAR T-Cell Immunotherapy Revenue in Global Market (2017-2022)
7.17.5 Creative Biolabs Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. CAR T-Cell Immunotherapy Market Opportunities & Trends in Global Market
Table 2. CAR T-Cell Immunotherapy Market Drivers in Global Market
Table 3. CAR T-Cell Immunotherapy Market Restraints in Global Market
Table 4. Key Players of CAR T-Cell Immunotherapy in Global Market
Table 5. Top CAR T-Cell Immunotherapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CAR T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CAR T-Cell Immunotherapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies CAR T-Cell Immunotherapy Product Type
Table 9. List of Global Tier 1 CAR T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CAR T-Cell Immunotherapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CAR T-Cell Immunotherapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CAR T-Cell Immunotherapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CAR T-Cell Immunotherapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CAR T-Cell Immunotherapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CAR T-Cell Immunotherapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie CAR T-Cell Immunotherapy Product Offerings
Table 32. AbbVie CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene CAR T-Cell Immunotherapy Product Offerings
Table 35. Celgene CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 36. Kite Pharma Corporate Summary
Table 37. Kite Pharma CAR T-Cell Immunotherapy Product Offerings
Table 38. Kite Pharma CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 39. Oxford BioMedica Corporate Summary
Table 40. Oxford BioMedica CAR T-Cell Immunotherapy Product Offerings
Table 41. Oxford BioMedica CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis CAR T-Cell Immunotherapy Product Offerings
Table 44. Novartis CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 45. Gilead Corporate Summary
Table 46. Gilead CAR T-Cell Immunotherapy Product Offerings
Table 47. Gilead CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer CAR T-Cell Immunotherapy Product Offerings
Table 50. Pfizer CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 51. Cellectis Corporate Summary
Table 52. Cellectis CAR T-Cell Immunotherapy Product Offerings
Table 53. Cellectis CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 54. Bellicum Corporate Summary
Table 55. Bellicum CAR T-Cell Immunotherapy Product Offerings
Table 56. Bellicum CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 57. Mustang Bio Corporate Summary
Table 58. Mustang Bio CAR T-Cell Immunotherapy Product Offerings
Table 59. Mustang Bio CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 60. CARsgen Therapeutics Corporate Summary
Table 61. CARsgen Therapeutics CAR T-Cell Immunotherapy Product Offerings
Table 62. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 63. Xyphos Corporate Summary
Table 64. Xyphos CAR T-Cell Immunotherapy Product Offerings
Table 65. Xyphos CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 66. Minerva Biotechnologies Corporate Summary
Table 67. Minerva Biotechnologies CAR T-Cell Immunotherapy Product Offerings
Table 68. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 69. Adaptimmune Corporate Summary
Table 70. Adaptimmune CAR T-Cell Immunotherapy Product Offerings
Table 71. Adaptimmune CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 72. Ziopharm Oncology Corporate Summary
Table 73. Ziopharm Oncology CAR T-Cell Immunotherapy Product Offerings
Table 74. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 75. Aurora Biopharma Corporate Summary
Table 76. Aurora Biopharma CAR T-Cell Immunotherapy Product Offerings
Table 77. Aurora Biopharma CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)
Table 78. Creative Biolabs Corporate Summary
Table 79. Creative Biolabs CAR T-Cell Immunotherapy Product Offerings
Table 80. Creative Biolabs CAR T-Cell Immunotherapy Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. CAR T-Cell Immunotherapy Segment by Type in 2021
Figure 2. CAR T-Cell Immunotherapy Segment by Application in 2021
Figure 3. Global CAR T-Cell Immunotherapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CAR T-Cell Immunotherapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CAR T-Cell Immunotherapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2021
Figure 8. By Type - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 12. US CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 16. Germany CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 17. France CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 24. China CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 28. India CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 30. Brazil CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CAR T-Cell Immunotherapy Revenue Market Share, 2017-2028
Figure 33. Turkey CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CAR T-Cell Immunotherapy Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Kite Pharma CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Oxford BioMedica CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gilead CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Cellectis CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bellicum CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mustang Bio CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Xyphos CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Minerva Biotechnologies CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Adaptimmune CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Ziopharm Oncology CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Aurora Biopharma CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Creative Biolabs CAR T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: CAR T-Cell Immunotherapy Market, Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Wound Care in Turkey

Wound Care in Turkey

Wound Care in Tunisia

Wound Care in Tunisia

Wound Care in Slovenia

Wound Care in Slovenia

Wound Care in Slovakia

Wound Care in Slovakia

Wound Care in Serbia

Wound Care in Serbia

Wound Care in China

Wound Care in China